Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Income from Discontinued Operations (2022 - 2023)

Updated

Pasithea Therapeutics (KTTA) posted Income from Discontinued Operations of -$16,895 for Q4 2023, compared with -$1.06 million a year earlier.

Analysis

Pasithea Therapeutics (KTTA) Income from Discontinued Operations (2022 - 2023) Analysis & Trends

For FY2023, Pasithea Therapeutics' Income from Discontinued Operations came in at -$453,910.

  • In prior years, Pasithea Therapeutics' Income from Discontinued Operations was -$2.21 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Pasithea Therapeutics 16.04 Mn 16.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -16,895.00
Jun 30, 2023 -165,146.00
Mar 31, 2023 -271,869.00
Dec 31, 2022 -1.06 Mn
Sep 30, 2022 -395,089.00
Jun 30, 2022 -468,535.00
Mar 31, 2022 -325,659.00
API Access

Pasithea Therapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=KTTA&period=max&api_key=YOUR_API_KEY